DAB2IP and glioblastoma: To investigate the molecular mechanism underlying the effects of DAB2IP regulating GBM-CSCs properties, we performed RNA-sequencing (RNA-seq) using DAB2IP modulated GBM cell lines (A172 Con/KD, U87MG Vc/OE, LN229 Vc/OE) and obtained potential DAB2IP target genes, which were commonly altered by DAB2IP in all cell lines (Fig. 2A, B, Fig. S3).